It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. To read this article on Zacks.com click here.

A unique, proprietary stock-rating model, the Zacks Rank uses earnings estimate revisions, or changes to a company's earnings expectations, to help investors create a winning portfolio.

Maplebear (CART) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate ...

A unique, proprietary stock-rating model, the Zacks Rank uses earnings estimate revisions, or changes to a company's earnings expectations, to help investors create a winning portfolio.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Clipper Realty (CLPR Quick Quote CLPR - Free Report) : This real estate investment trust which specializes in acquiring, owning ...

Jackson Financial (JXN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

Zacks Trade offers penny-a-share trades, a robust trading platform and, unlike most brokers, doesn't charge extra for broker-assisted trades. Many, or all, of the products featured on this page ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 25: BRF S.A.